Medium term planning of biopharmaceutical manufacture with uncertain fermentation titersLAKHDAR, Kais; FARID, Suzanne S; TITCHENER-HOOKER, Nigel J et al.Biotechnology progress. 2006, Vol 22, Num 6, pp 1630-1636, issn 8756-7938, 7 p.Article

Strategic Biopharmaceutical Portfolio Development : An Analysis of Constraint-Induced ImplicationsGEORGE, Edmund D; FARID, Suzanne S.Biotechnology progress. 2008, Vol 24, Num 3, pp 698-713, issn 8756-7938, 16 p.Conference Paper

Biomédicaments : des perspectives thérapeutiques prometteuses dans le traitement des formes modérées à sévères du psoriasis en plaquesMADIOU, Jean-Philippe.Images en dermatologie. 2012, Vol 5, issn 1964-4167, 17 p., SUPSerial Issue

Multiobjective Long-Term Planning of Biopharmaceutical Manufacturing FacilitiesLAKHDAR, K; SAVERY, J; PAPAGEORGIOU, L. G et al.Biotechnology progress. 2007, Vol 23, Num 6, pp 1383-1393, issn 8756-7938, 11 p.Article

The antibody paradigm: present and future development as a scaffold for biopharmaceutical drugsJEFFERIS, Roy.Biotechnology & genetic engineering reviews. 2010, Vol 26, pp 1-41, issn 0264-8725, 41 p.Article

Biomédicaments en France: État des lieux en 2004 : Étude menée par les entreprises du médicament (regroupées au sein du Leem) pour établir un état des lieux des biomédicaments disponibles en France en 2004 = State of biopharmaceuticals in France : 2004 retrospective analysisCLERGEOT, A; ARNOUX, P. Y; LASSALE, C et al.La Lettre du pharmacologue (Boulogne). 2005, Vol 19, Num 3, pp 74-81, issn 0984-452X, 8 p.Article

Les biomédicaments de demain se fabriquent aujourd'hui = BiodrugsWIEZBICKI, Julie.Biofutur (Puteaux). 2005, Num 260, pp 38-42, issn 0294-3506, 5 p.Article

GMP issues for recombinant plant-derived pharmaceutical proteinsFISCHER, Rainer; SCHILLBERG, Stefan; HELLWIG, Stephan et al.Biotechnology advances. 2012, Vol 30, Num 2, pp 434-439, issn 0734-9750, 6 p.Article

Microtools for single-cell analysis in biopharmaceutical development and manufacturingLOVE, Kerry Routenberg; BAGH, Sangram; CHOI, Jonghoon et al.Trends in biotechnology (Regular ed.). 2013, Vol 31, Num 5, pp 280-286, issn 0167-7799, 7 p.Article

Demonstration of Robust Host Cell Protein Clearance in Biopharmaceutical Downstream ProcessesSHUKLA, Abhinav A; CANPING JIANG; JUNFEN MA et al.Biotechnology progress. 2008, Vol 24, Num 3, pp 615-622, issn 8756-7938, 8 p.Conference Paper

Multivariate PAT solutions for biopharmaceutical cultivation: current progress and limitationsMERCIER, Sarah M; DIEPENBROEK, Bas; WIJFFELS, Rene H et al.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 6, pp 329-336, issn 0167-7799, 8 p.Article

Biopharmaceuticals from Plants : A Multitude of Options for Posttranslational ModificationsWARZECHA, Heribert.Biotechnology & genetic engineering reviews. 2008, Vol 25, pp 315-330, issn 0264-8725, 16 p.Article

Continuous downstream processing of biopharmaceuticalsJUNGBAUER, Alois.Trends in biotechnology (Regular ed.). 2013, Vol 31, Num 8, pp 479-492, issn 0167-7799, 14 p.Article

Proteins behaving badly: emerging technologies in profiling biopharmaceutical aggregationHAMRANG, Zahra; RATTRAY, Nicholas J. W; PLUEN, Alain et al.Trends in biotechnology (Regular ed.). 2013, Vol 31, Num 8, pp 448-458, issn 0167-7799, 11 p.Article

Post-translational modifications of protein biopharmaceuticalsWALSH, Gary.Drug discovery today. 2010, Vol 15, Num 17-18, pp 773-780, issn 1359-6446, 8 p.Article

What's fueling the biotech engine?AGGARWAL, Saurabh.Nature biotechnology (Print). 2007, Vol 25, Num 10, pp 1097-1104, issn 1087-0156, 8 p.Article

Passive Multivariable Temperature and Conductivity RFID Sensors for Single-Use Biopharmaceutical Manufacturing ComponentsPOTYRAILO, Radislav A; WORTLEY, Timothy; KLENSMEDEN, Staffan et al.Biotechnology progress. 2011, Vol 27, Num 3, pp 875-884, issn 8756-7938, 10 p.Article

Single-use disposable technologies for biopharmaceutical manufacturingSHUKLA, Abhinav A; GOTTSCHALK, Uwe.Trends in biotechnology (Regular ed.). 2013, Vol 31, Num 3, pp 147-154, issn 0167-7799, 8 p.Article

Purifying biopharmaceuticals: knowledge-based chromatographic process developmentHANKE, Alexander T; OTTENS, Marcel.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 4, pp 210-220, issn 0167-7799, 11 p.Article

Structural instability of plasmid biopharmaceuticals: challenges and implicationsOLIVEIRA, Pedro H; JONES PRATHER, Kristala; PRAZERES, Duarte M. F et al.Trends in biotechnology (Regular ed.). 2009, Vol 27, Num 9, pp 503-511, issn 0167-7799, 9 p.Article

Les anticorps monoclonaux, moteur de la croissance de l'industrie pharmaceutiqueOSSIPOW, Vincent.Biofutur (Puteaux). 2009, Num 300, pp 62-63, issn 0294-3506, 2 p.Article

Estimating production technical efficiency for the US biopharmaceutical industryLIN, Yi-Hsing; HONG, Chun-Fu.International journal of biotechnology. 2012, Vol 12, Num 3, pp 184-197, issn 0963-6048, 14 p.Article

Antibody cocktails : next-generation biopharmaceuticals with improved potencyLOGTENBERG, Ton.Trends in biotechnology (Regular ed.). 2007, Vol 25, Num 9, pp 390-394, issn 0167-7799, 5 p.Article

Cellular targets for improved manufacturing of virus-based biopharmaceuticals in animal cellsRODRIGUES, Ana F; CARRONDO, Manuel J. T; ALVES, Paula M et al.Trends in biotechnology (Regular ed.). 2014, Vol 32, Num 12, pp 602-607, issn 0167-7799, 6 p.Article

A special report on India's biotech scenario: Advancement in biopharmaceutical and health care sectorsCHAKRABORTY, Chiranjib; AGORAMOORTHY, Govindasamy.Biotechnology advances. 2010, Vol 28, Num 1, pp 1-6, issn 0734-9750, 6 p.Article